Skip to Content

Lofibra 134 mg Gate 323 (Lofibra 134 mg)

Generic Name: fenofibrate

Pill with imprint Lofibra 134 mg Gate 323 is Blue, Capsule-shape and has been identified as Lofibra 134 mg. It is supplied by Gate Pharmaceuticals.

Lofibra is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Lofibra 134 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Lofibra 134 mg Gate 323

Lofibra 134 mg Lofibra 134 mg Gate 323
Lofibra 134 mg Lofibra 134 mg Gate 323
Lofibra 134 mg Lofibra 134 mg Gate 323

Lofibra

Generic Name
fenofibrate
Imprint
Lofibra 134 mg Gate 323
Strength
134 mg
Color
Blue
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Gate Pharmaceuticals
National Drug Code (NDC)
57844-0323
Inactive Ingredients
croscarmellose sodium, lactose monohydrate, magnesium stearate, povidone k25, corn starch, sodium lauryl sulfate, magnesium silicate, D&C Red No. 28, FD&C Blue No. 1, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.